Cardiovascular toxicities associated with novel cellular immune therapies∗
Malak Munir, Ahmed Sayed, Daniel Addison, Narendranath Epperla · 2024
Read Cardiovascular toxicities associated with novel cellular immune therapies∗ by Malak Munir, Ahmed Sayed, Daniel Addison, Narendranath Epperla (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11698921.txt.
Description
New cell therapies that aim T cells at cancer can also strain the heart. Malak Munir, Ahmed Sayed, Daniel Addison, and Narendranath Epperla review the toll in 2024. Three cures fall in scope: lab-armed T cells, bridge drugs that link T cells to cancer, and T cells pulled from the tumor itself. Reports tie them to racing or wild heartbeats, weak pumping, heart swelling, and bleeds. Such events now cap how long folk live after the cures work.
The review sorts rates, risk traits, and care steps for each ill. A storm of immune signals explains part of the harm, but not all of it. Gaps the team flag include which hearts are at risk before treatment and how to guard them. They call for heart checks to be built into these cures from the start.
Catalog record
| CREATOR | Malak Munir, Ahmed Sayed, Daniel Addison, Narendranath Epperla |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |